[Translate to Englisch:] ZKS Logo - Copyright: Figiel, Tom

Center for Clinical Trials: Our range of services

The Center for Clinical Trials (ZKS) at MHH offers academic researchers, as well as pharmaceutical and medical device companies, first-class conditions for competent and rapid implementation of all phases of their clinical trial - "on time and on budget" at Hanover Medical School (MHH ).

CRO - Services for IITs and for industry sponsors

We serve all aspects of an academic CRO for the successful realisation of AMG and MDR/MPDG - projects, as well as non-interventional studies for Investigator Initiated Trials (IITs) with MHH sponsorship and contract research projects with external sponsor:

  • Trial consulting and project development
  • Project management
  • Site management
  • Budget planning & financial management
  • Clinical monitoring
  • Data management (with MARVIN, by XClinical)
  • Quality management (ISO9001 certified)
  • Biometrics & Pharmacovigilance (cooperating with the MHH Institutes for Biometrics and Clinical Pharmacology)
  • Medical writing and submission to authorities via CTIS (EK, BfArM, PEI)

Experienced phase I unit for early and translational Proof of Concept (PoC) trials including First in Human (FIH) trials

The Clinical Research Center Hanover provides your research-based pharmaceutical company with a fully equipped clinical-operative Early Clinical Trial Unit (ECTU) that has been employed by MHH since 2014 and that has retained its Early Phase Medical Team from that time on. Here, healthy volunteers and patients who are generally mobile and do not require special care can be treated and medically monitored as part of early phase study protocols. The clinical trial unit is operated together with CRC partner Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), with both legal entities, Fraunhofer ITEM and MHH, employing their respective medical early phase teams in the CRC at the ECTU.

Clinical research in all indication areas and development phases (I - IV)

ZKS covers every development phase in clinical research and every medical indication area, with the research priorities of the MHH - 1) infection and immunity 2) transplantation and regeneration 3) biomedical technology and implants 4) oncology (the latter in close cooperation with the CCC Lower Saxony) - at its core and works closely with the clinics of the MHH as a university clinic for supramaximal care and all MHH teaching hospitals in the Hanover region in order to ensure the timely recruitment of patients.

FRMU Contract Consulting Services

The FRMU provides support with business issues relating to economic projects with a volume > 50,000 € according to the MHH third-party funding guideline. Consulting services include financial and risk management as well as developing a budget proposal.

ZKS – MHH: Current news and projects

read more

ZKS SPOTLIGHT, the sequel!

For the second time we are presenting current news and the latest developments relating to clinical research at the MHH. Studies in focus: EXCHANGE-2, CARAML and KAR-Alexion. We also show the…

to download page

The Study Location Germany Initiative (ISD) is working

Habemus Medical Research Act (MFG). The new MFG came into force with its publication in the Federal Law Gazette on October 30, 2024.

On November 8, 2024, the experts from the Study Location…

read more

1st MHH RWD Day

On 29/5/2024, the 1st MHH Real-World Data Day took place at the MHH. Experts from the ...

read more

DGPharMed Annual Congress

Enlightening discussions at the 40th annual congress of DGPharMed in Mainz: The KKS Network e.V. was there!

read more

Face-To-Face GCP courses (AMG/MPDG) in 2024

2024-11-11: AMG basic course
2024-13-11: AMG refresher
2024-18-11: 
MPDG basic course
2024-19-11: AMG advanced course

read more

Fact Sheet

KKS network publishes facts about clinical trials.

Download
[Translate to Englisch:] Copyright: Arek Socha (Pixabay)

Looking for study participants

The ZKS study team is looking for subjects for various studies. You can find out whether you meet the participation requirements by clicking on the link below ...

learn more

Review of the 5th translation workshop

Renowned personalities from translational research thrilled the audience ...

Click here to go to the EKFS page (including the option to download the lectures)

5th translation workshop

"How can we improve the benefits of medical research for patients?"

MHH – ZKS presents translation infrastructure in Frankfurt.

read more

Prof. Dr. Christoph Schindler at EWMA 2023 in Milan

The head of the ZKS presented the results of a phase 1 study on the effectiveness of AUP-16 on diabetic foot ulcers.

read more

CTIS at the MHH

EU Regulation 536/2014 (Clinical Trial Regulation, CTR) has been valid since January 31, 2022. Since then, all new applications for clinical trials with medicinal products can and from January…

read more

First interdisciplinary medicinal device study started in the new ZKS in the CRC

The Department of Trauma Surgery and the medical team from the Early Clinical Trial Unit of the Center for Clinical Studies (ZKS) jointly initiated the industry-sponsored RESTORE study. This…

read more

The Medical Device Regulation (MDR) came into force on May 26, 2021

The Medical Device Regulation (MDR) (Regulation (EU) 2017/745) has come into force since May 26, 2021. The national implementation is regulated, among other things, by the Medical Devices…

read more

The ZKS is working on 5 COVID research projects

The newly founded ZKS is currently working on 5 active clinical research projects on the topic of COVID. A major focus here is on the development and improvement of vaccines against COVID-19. But…

read more

Laying of the foundation stone and kick-off event for the new Center for Clinical Studies (ZKS) at the MHH

The Center for Clinical Studies (ZKS) at the MHH was consolidated by executive resolution on May 6, 2021. Under the direction of Prof. Christoph Schindler, the ZKS at the MHH operates as a staff…

read more